The frequencies of genomic alterations involved in TCR-signaling/NF kappa-B, immune surveillance, PI3K/AKT/mTOR, and tumor suppressor were significantly higher in C2 than in the other subtypes (Fig. 5b). The gene discussed is MTOR; the disease is neoplasm.